The NS5a gene of hepatitis C virus in patients treated with interferon- α

Journal of Medical Virology

Volumn 60, Issue 4, 2000, Pages 367-378

  McKechnie, Victoria M ^a   Mills, Peter R ^b   McCruden, Elizabeth A B ^a,b,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

Hepatitis C virus; Nucleotide sequencing; Response to interferon therapy; Single stranded conformation polymorphism

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; VIRUS PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; LIVER HISTOLOGY; MALE; NUCLEOTIDE SEQUENCE; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS GENE; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; AMINO ACID SEQUENCE; FEMALE; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TREATMENT OUTCOME; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0033996227     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200004)60:4<367::AID-JMV2>3.0.CO;2-6     Document Type: Article

References (35)

1. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. 1997. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341-1347.
2. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G , Houghton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
3. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed AA, Teo D, Conradie J, Kew MC, Yap PL. 1995. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 76:1197-1204.
4. Davis GL, Lau JY. 1997. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26:122S-127S.
5. Duverlie G, Khorsi H, Castelain S, Jaillon O, Izopet J, Lunel F, Eb F, Penin F Wychowski C. 1998. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol 79:1373-1381.
6. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. 1994. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 75:361-369.
7. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. 1995. Comparison of fulllength sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230.
8. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81.
9. Fujii K, Hino K, Okazaki M, Okuda M, Kondoh S, Okita K. 1996. Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells. Biochem Biophys Res Commun 225:771-776.
10. Gale MJ Jr, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
11. Gale M Jr., Blakely CM, Kwleciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18: 5208-5218.
12. Gale MJ Jr., Korth MJ, Katze MG. 1998. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 10:157-162.
13. Gonzalez-Peralta RP, Qian K, She JY, Davis GL, Ohno T, Mizokami M, Lau JYN. 1996. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol 49:242-247.
14. Harada K, Watanabe H, Shijo H ,Okumura M. 1996. Predictive factors regarding the responsiveness to inteferon therapy for patients with chronic hepatitis C: an assessment of the hypervariable region 1 quasispecies in genotype 1b of chronic hepatitis C. Int Hepatol Commun 5:215-220.
15. Hofgartner WT, Polyak SJ, Sullivan DG, Carithers RL Jr., Gretch DR. 1997. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 53:118-126.
16. Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, Sasaguri Y, Padmanabhan R. 1996. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182:203-211.
17. Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM. 1991. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci USA 88:10292-10296.
18. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. 1995. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
19. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A non-B hepatitis. Proc Natl Acad Sci USA 87:9524-9528.
20. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
21. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225-3229.
22. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, Igimi H, Kamada T, Uchida K. 1995. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108: 789-795.
23. Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D. 1998. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 72:2795-2805.
24. Peters T, Schlayer HJ, Hiller B, Rosler B, Blum H, Rasenack J. 1997. Quasispecies analysis in hepatitis C virus infection by fluorescent single strand conformation polymorphism. J Virol Methods 64:95-102.
25. Reed KE, Xu J, Rice CM. 1997. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J Virol 71:7187-7197.
26. Saiz JC, Lopez-Labrador FX, Ampurdanes S, Dopazo J, Forns X, Sanchez-Tapias JM, Rodes J. 1998. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 177:839-847.
27. Sakamoto M, Akahane Y, Tsuda F, Tanaka T, Woodfield DG, Okamoto H. 1994. Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a. J Gen Virol 75:1761-1768.
28. Satoh S, Hirota M, Hijikata M, Kato N, Handa H, Shimotohno K. 1998. The hepatitis C virus NS5A protein complexes with the interferon-induced double-stranded RNA dependent protein kinase, PKR, in mammalian cells. International Meeting on Hepatitis C Virus and Related Viruses - Molecular Virology and Pathogenesis, Venice, Italy.
29. Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okuno T. 1996. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 24:1018-1023.
30. Song J, Fujii M, Wang F, Itoh M, Hotta H.1999. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J Gen Virol 80:879-886
31. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, Brechot C. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113:567-572.
32. Tanji Y, Kaneko T, Satoh S, Shimotohno K. 1995. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69:3980-3986.
33. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
34. Toyoda H, Fukada Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. 1997. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepataol 26: 975-982.
35. Wisconsin Package Version 9.1. Genetics Computer Group (GCG) Madison, Wisconsin.